Ivan Milinkovic
Overview
Explore the profile of Ivan Milinkovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simeunovic D, Milinkovic I, Polovina M, Trifunovic Zamaklar D, Veljic I, Zaharijev S, et al.
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005382
Cardiac tamponade is managed through echo- or fluoroscopy-guided percutaneous pericardiocentesis. The European Society of Cardiology's Working Group on Myocardial and Pericardial Diseases proposed a triage strategy for these patients. This...
2.
Shchendrygina A, Mewton N, Niederseer D, Kida K, Guidetti F, Jobbe Duval A, et al.
Am J Cardiol
. 2024 Oct;
236():42-48.
PMID: 39481586
Cardiac amyloidosis (CA) is still an underdiagnosed cause of heart failure (HF) and early disease recognition and timely disease-modifying therapy (DMT) administration translate to better outcomes. We aimed to assess...
3.
Saldarriaga C, de Gracia S, Palacio Mejia M, Shchendrygina A, Kida K, Fauvel C, et al.
Curr Probl Cardiol
. 2024 Aug;
49(12):102799.
PMID: 39214158
Background And Aims: There is a gap in knowledge about implementing diagnostic tools and therapy for heart failure with preserved ejection fraction (HFpEF) in clinical practice. This survey aimed to...
4.
Seferovic P, Paulus W, Rosano G, Polovina M, Petrie M, Jhund P, et al.
Eur J Heart Fail
. 2024 Jun;
26(9):1893-1903.
PMID: 38896048
The association between type 2 diabetes mellitus (T2DM) and heart failure (HF) has been firmly established; however, the entity of diabetic myocardial disorder (previously called diabetic cardiomyopathy) remains a matter...
5.
Bayes-Genis A, Krljanac G, Zdravkovic M, Asanin M, Stojsic-Milosavljevic A, Radovanovic S, et al.
ESC Heart Fail
. 2023 Dec;
11(2):672-680.
PMID: 38093494
Aims: Natriuretic peptide (NP) uptake varies in Emergency Departments (EDs) across Europe. The 'Peptide for Life' (P4L) initiative, led by Heart Failure Association, aims to enhance NP utilization for early...
6.
Bruni C, Buch M, Djokovic A, Luca G, Dumitru R, Giollo A, et al.
J Scleroderma Relat Disord
. 2023 Sep;
8(3):169-182.
PMID: 37744047
Introduction: Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on...
7.
Seferovic P, Polovina M, Rosano G, Bozkurt B, Metra M, Heymans S, et al.
Eur J Heart Fail
. 2023 Jul;
25(11):1899-1922.
PMID: 37470300
Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Over the past decades, a progress has occurred in characterization of the genetic background and major pathophysiological mechanisms, which has been...
8.
Seferovic P, Polovina M, Milinkovic I, Anker S, Rosano G, Coats A
Int J Heart Fail
. 2022 Oct;
3(4):205-218.
PMID: 36262556
Over the past three decades, pharmacological treatment of heart failure (HF) with reduced ejection fraction (HFrEF) has witnessed a significant progress with the introduction of multiple disease-modifying therapies with a...
9.
Seferovic P, Rosano G, Vardas P, Milinkovic I, Polovina M, Timmis A, et al.
Eur Heart J
. 2022 Oct;
43(48):4973-4975.
PMID: 36201512
No abstract available.
10.
Seferovic P, Polovina M, Milinkovic I, Krljanac G, Asanin M
Eur J Prev Cardiol
. 2022 Aug;
31(2):272-273.
PMID: 35950368
No abstract available.